Reading a Term Sheet: The Price Is the Headline, the Terms Are the Deal
Founders negotiate the one number they understand and sign everything around it. The valuation is the headline. The terms are the contract, and the contract is where outcomes are decided.

When the term sheet finally arrives, founders read one number and celebrate. The valuation is the score they have been keeping all raise, the number that gets announced, the number their friends will hear. So they negotiate it hard, win a little, and then sign the eight pages wrapped around it more or less as delivered. This is exactly backwards. The valuation determines how you feel this month. The terms determine what you actually get paid, who controls the company, and what your next round looks like, for as long as the company exists.
Investors know this asymmetry and, reasonably, use it. A fund that concedes a flattering headline number and recovers the value through preference, participation, or control has given up the thing you were watching in exchange for the things you were not. The defense is not paranoia. It is knowing which four or five clauses do the work.
The liquidation preference is the real price
The preference decides who gets paid first, and how much, when the company is sold. At a huge exit it is irrelevant, which is why everyone models the huge exit when they sign. But most real exits are modest, and at a modest exit the preference is the entire negotiation you did or did not have. Drag the sliders and watch: the same cap table produces wildly different founder outcomes depending on one clause nobody argued about.
An investor puts in the amount below for the ownership below, with the liquidation preference you choose. Set the exit value and watch who the clause pays. The preference does nothing at a big exit and decides everything at a small one.
At this exit the preference is doing the work: the investor takes $10M first (1x the $10M they put in), 25% of the whole outcome for 25% ownership, and everyone else splits $30M. The headline valuation never mentioned this.
The market standard at seed and Series A is a 1x non-participating preference, and you should treat anything beyond it as a price cut in disguise. Flip the simulator to 2x and watch the founders' column at a modest exit: the multiple doubles what comes off the top before you see a dollar, and stacked across rounds it can swallow an entire mid-size outcome. A 2x preference or a participating structure at a higher valuation is frequently worth less to you than a clean 1x at a lower one. If a fund offers a trophy headline with heavy structure underneath, they are not paying the trophy price. They are renting your announcement.
Control terms outlast every number
The economic terms decide the split at the end. The control terms decide who steers until then, and they are harder to see because they do not have numbers attached. The board composition clause determines who can replace you. The protective provisions determine what you cannot do without investor consent: sell the company, raise the next round, change the option pool. None of this matters while everyone agrees, which is precisely the trap. Control terms are written for the day everyone stops agreeing, and they are unchangeable by then.
The quieter clauses that bite later
- Anti-dilution. If the next round prices lower, this formula decides how much of the pain is yours. Broad-based weighted average is standard and survivable. Full ratchet is not, and its presence tells you something about the fund.
- Pro rata rights. Reasonable for the lead. But stacked, they can crowd the next round: if existing investors have rights to most of the Series A, new leads have nothing to buy.
- The option pool, twice. First, where it is created: a pool carved out pre-money is dilution only the existing holders eat, while a pool created post-money is shared with the new investor, and the headline valuation looks identical either way. We walked through that arithmetic in how much to raise. Second, how it is sized: build it bottom-up from your actual hiring plan, including refresh grants for the early employees whose grants have mostly vested, not just the executive the investor wants you to recruit. A pool sized by someone else's default is a price cut sized by someone else's default.
- Tranched money. An offer to invest in stages, with more capital released at milestones, reads as generous and is usually the opposite. If the company struggles, the later tranches come with outs, so the guarantee was never real. If the company works, you are committed to selling more equity at the old price at exactly the moment it is worth more, or to absorbing money you no longer need. Never commit today to taking more than the plan requires. Keep the decision about the next dollar in your hands, not theirs.
- Founder vesting reset. Re-vesting some equity is normal. Resetting years you have already earned is a negotiation, not a default, and it is worth more to you than valuation points.
Primary checks, secondary checks
Not every dollar in a round does the same job. Primary money buys newly issued shares: the cash lands on the company's balance sheet, everyone dilutes a little, and the business gets runway. Secondary money buys existing shares from someone who already holds them, usually a founder, an early employee, or an angel: the seller gets the cash, the company gets nothing, and no new shares are created. Term sheets sometimes present the two as one headline number. They are opposite instruments, and they deserve opposite instincts.
- Good: a modest founder secondary once the company has earned it. By the time of a competitive Series B, a founder with years of below-market salary and an entire net worth in one illiquid stock has a quiet incentive to sell the company at the first decent offer. A single-digit-percent secondary removes that pressure without removing the hunger, which is why thoughtful investors sometimes propose it themselves.
- Good: cleaning the cap table. Buying out a departed co-founder or an early holder who wants out turns a permanent complication into a closed chapter, and secondary is the mechanism built for exactly that.
- Bad: liquidity before proof. Asking for secondary at seed or Series A, before the company has demonstrated much of anything, tells the investor you want the reward before the risk. It sours otherwise good rounds remarkably fast.
- Bad: taking so much off the table that the bet changes. The investor is underwriting a founder with something to prove and something at stake. A secondary large enough to make you personally finished rewrites both halves of that sentence.
- Unnecessary: most of the time. A secondary dollar buys the company nothing: no runway, no milestone, no next round. If nobody on the cap table actually needs the liquidity, bolting secondary onto a clean deal only adds complexity. Skip it without regret.
One mechanical note. Secondary is usually common stock, which lacks the very preference this article is about, so it should price at a discount to the preferred sold in the same round. A secondary done at the full preferred price is mispriced, and the mispricing leaks into your 409A valuation and the strike price of every option you grant afterward.
How to read the thing
- Model every offer at three exits: a disappointing one, a decent one, and the dream. Compare founder proceeds, not headlines. The ranking of offers often flips at the modest exit.
- Get a lawyer who does venture deals weekly, not your cousin who does real estate. The market standard moves, and knowing what is currently standard is most of your leverage.
- Ask the investor to walk you through every non-standard term and why they need it. A good fund explains calmly. A fund that bristles at the question is answering it.
- Negotiate the preference and the board before the price. If those are clean, a fair price follows. If those are dirty, no price fixes it.
- Remember leverage comes from options, not arguments. A single term sheet negotiates itself. Two negotiate each other, which is the entire case for running your raise like a process.
- 1x non-participating liquidation preference
- Broad-based weighted average anti-dilution
- A board you can live with for a decade: founders plus the lead, no dead weight
- Standard protective provisions, nothing that needs consent for ordinary operations
- Participating preferred, multiple preferences, or a full ratchet
- Milestone tranches you are obligated to draw whether or not you need them
- A vesting reset on equity you have already earned
The valuation is what they say you are worth. The terms are what you actually agreed to. Only one of them is enforceable.
None of this means treating investors as adversaries. The good ones offer clean terms precisely because they expect to make money on the company, not on the structure, and a clean term sheet is one of the strongest signals you get about who you are letting onto the cap table. Read the whole document, model the modest exit, and negotiate the clauses that outlive the announcement. And before any of that, earn the leverage to negotiate at all: multiple offers come from materials that survive scrutiny, which is what Roast My Startup is for.
Find the holes before an investor does
Roast My Startup is a firm of AI analysts that tears apart your deck, model, forecast, and data room, then tells you exactly what an investor would use to pass. Brutal first, constructive second.